BackFive Prime Therapeutics Overview

Five Prime Therapeutics Long Term Debt

Track Five Prime Therapeutics's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average

Loading

Five Prime Therapeutics Long Term Debt History

Loading

Five Prime Therapeutics vs. peers: Long Term Debt Comparison

Loading

Five Prime Therapeutics Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Five Prime Therapeutics (FPRX) FAQ

Five Prime Therapeutics (FPRX) currently reports a long-term debt of $0 as of December 2020. In the prior-year period, the figure was $0. Use the charts on this page to explore Five Prime Therapeutics's long-term debt history and peer comparisons.

Five Prime Therapeutics's long-term debt changed from $0 to $0 (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Five Prime Therapeutics reported $0 in long-term debt as of December 2020. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Five Prime Therapeutics, and consider following FPRX for alerts when major investors trade the stock.

Five Prime Therapeutics is classified in the Healthcare sector. On long-term debt, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FPRX with unrelated industries.